🔍
Search Results - john+schiller
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Unexpected Cross-neutralization of Cutaneous & Mucosal Papillomavirus Types with Anti-Sera to a Novel L2 Epitopes
C04603: Unexpected Cross-neutralization of Cutaneous & Mucosal Papillomavirus Types with Anti-Sera to a Novel Epitopes Technical Details: High risk Human Papillomavirus (HPV) infection is a common cause of cervical cancer. Researchers at JHU have found that vaccination with the N terminus of HPV16 and bovine papillomavirus 1 can induce cross...
Published: 3/13/2025
|
Inventor(s):
John Schiller
,
Douglas Lowy
,
Diane Pastrana
,
Ratish Gambhira
,
Richard Roden
Keywords(s):
Biologics
,
Cancers
,
Cervical Cancer
,
Disease Indication
,
Human Papillomavirus (HPV)
,
Infectious Diseases
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Vaccine
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Oncology > Cervical Cancer
,
Clinical and Disease Specializations > Women's Health
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Vaccines
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
,
Clinical and Disease Specializations > Infectious Diseases > Human Papillomavirus (HPV)
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum